Skip to content

Clinical trials

Phase 2 Amyloidosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Phase: Phase 2 Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20081
20091
20111
20122
20131
20141
20163
20172
20181
20191
20213
20221
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated6
Recruiting4
Active, not recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital2
GlaxoSmithKline2
Mayo Clinic2
Attralus, Inc.1
Boston Medical Center1
Boston University1
Columbia University1
Eidos Therapeutics, a BridgeBio company1
Herbert Irving Comprehensive Cancer Center1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis27
Immunoglobulin Light-chain Amyloidosis7
Alzheimer Disease5
Multiple Myeloma5
Paraproteinemias3
Amyloid Neuropathies, Familial2
Cardiomyopathies2
Hematologic Neoplasms2
Polyneuropathies2
Amyloidosis, Familial1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.